Getz, Ted M.
Bakirhan, Kamila
Seropian, Stuart
Shallis, Rory M.
Article History
Received: 30 January 2025
Accepted: 26 April 2025
First Online: 27 June 2025
Declarations
:
: No funding was received for conducting this study. RMS had a consultancy with Bristol Myers Squibb, Curio Science, Gilead Sciences, Kura Oncology, Servier, and Rigel and served in Steering Committees for Servier. TMG, KB, and SS have no relevant financial or non-financial interests to disclose. The participant has consented to the submission of the case report to the journal. This case report adheres to the ethical standards set by Yale New Haven Hospital.
: RMS had a consultancy with Bristol Myers Squibb, Curio Science, Gilead Sciences, Kura Oncology, Servier, and Rigel and served in Steering Committees for Servier.